Author

Heather Frazier

Observed name: Heather K. Frazier

Observed institution: Southeast Retina Center

OpenAlex ID: A5035714910

Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial

2016 · Chelsea Fechter, Heather Frazier, et al. · Ophthalmic surgery, lasers & imaging retina · 26

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy in a Predominantly Non-Asian Population: RIVAL Results

2017 · Amina Farooq, Heather Frazier, et al. · Ophthalmic surgery, lasers & imaging retina · 4

Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage

2023 · Venkatkrish M. Kasetty, Davis C. Starnes, et al. · Ophthalmic surgery, lasers & imaging retina · 3

Endolaserless Vitrectomy With Intravitreal Aflibercept Injection for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage (LASER LESS TRIAL)

2018 · Dennis M. Marcus, Harinderjit Singh, et al. · Journal of VitreoRetinal Diseases · 3

Complications, Compliance and 3-Year Outcomes after Endolaserless Vitrectomy with Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage

2021 · Venkatkrish M. Kasetty, Davis Starnes, et al. · Investigative Ophthalmology & Visual Science · 1

Complications, Compliance and 2 Year Outcomes after Endolaserless Vitrectomy with Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage

2020 · Rachel A. Levy, Davis Starnes, et al. · Investigative Ophthalmology & Visual Science

Endolaserless vitrectomy with aflibercept for proliferative diabetic retinopathy-related vitreous hemorrhage (LASER LESS TRIAL):1-Year Results.

2020 · Dennis M. Marcus, Davis Starnes, et al. · Clinical ophthalmology

Optical coherence tomography angiographic, visual acuity and anatomic outcomes with aflibercept for diabetic macular edema after bevacizumab and/or ranibizumab.

2019 · Dennis M. Marcus, Heather Frazier, et al. · Clinical ophthalmology

Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

2018 · Caitlen Taylor, Heather Frazier, et al. · Investigative Ophthalmology & Visual Science

Ranibizumab (0.3 MG) For Persistent Diabetic Macular Edema (DME) After Recent, Frequent, And Chronic Bevacizumab: 1-Year Rotate Trial Results

2016 · Amina Farooq, Heather Frazier, et al. · Investigative Ophthalmology & Visual Science

Intravitreal Aflibercept For Neovascular Polypoidal Choroidal Vasculopathy In A Predominantly Non-Asian Population: 1-Year Rival Trial Results

2016 · Dennis M. Marcus, Amina Farooq, et al. · Investigative Ophthalmology & Visual Science

Works count: 11

Citation count: 37

H-index: 3

I10-index: 1